WAIKOLOA, Hawaii — At Hawaiian Eye, Roxana Ursea, MD, discusses the applications for amniotic membrane in treatment of ocular surface diseases. Among newer indications are to reduce scarring in postsurgical strabismus patients, to prevent haze in post-PRK patients and to promote epithelial healing in post-transplant patients.
Nicox has entered into a licensing agreement that grants Ora exclusive worldwide rights for the development and commercialization of Nicox’s AC-120 for the treatment of morning eyelid swelling, according to a press release. Under the terms of the agreement, Ora will be responsible for development activities and funding of the program through its investment arm.
The Pentacam AXL has received 510(k) clearance from the FDA, Oculus announced in a press release.The device, which combines anterior segment tomography and optical biometry for premium IOL calculation, integrates standard IOL formulas and ray-tracing f…
The FDA has acknowledged receipt of a new drug application resubmitted by Shire for lifitegrast to treat signs and symptoms of dry eye disease, the company announced in a press release.Shire resubmitted the application in response to a complete respons…
WAIKOLOA, Hawaii — At Hawaiian Eye, Andrew G. Lee, MD, discusses neuro-ophthalmology as an “ophthalmic superpower,” which enables ophthalmologists to home in on life- and vision-threatening neuro-ophthalmic conditions by assessing the patient’s pupil.
(MedPage Today) — In first one on one, candidates joust on healthcare and achievable goals